02192018Headline:

Archives

Home

Eric T. Chaffin

Herbicides Like Glyphosate Could Contribute to Antibiotic-Resistant Bacteria

The Centers for Disease Control and Prevention (CDC) reports that each year at least two million people become infected with antibiotic-resistant bacteria in the United States, and that at least 23,000 of them die from these infections. Antibiotics are designed […]

Eric T. Chaffin

Will the JPML Approve Consolidation of Onglyza Lawsuits?

If you’ve filed an Onglyza lawsuit, or if you’re thinking about it, mark January 25, 2018 on your calendar. That is the day that the U.S. Judicial Panel on Multidistrict Litigation will be hearing arguments about whether to consolidate all […]

Roopal Luhana

J&J Seeking to Expand Use of Xarelto Despite Side Effects

More than 20,500 Xarelto lawsuits are pending in consolidated litigation in the U.S. District Court for the Eastern District of Louisiana, and another 1,400 are pending in a mass tort in Philadelphia. Plaintiffs claim that after taking the blood-thinning medication, […]

Emily Beeson

Plaintiffs win big in Xarelto lawsuit

A Pennsylvania state court has returned a verdict in favor of a person injured by the blood thinner Xarelto in the amount of almost $28 million. The verdict comes on the heels of the third defense verdict in the consolidated […]

Roopal Luhana

AndroGel and Axiron Trials Scheduled for January

In June 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally-filed testosterone replacement lawsuits into one court in the Northern District of Illinois. District Court Judge Matthew Kennelly is overseeing the pre-trial proceedings. The lawsuits before Judge […]

Roopal Luhana

Indiana Couple Wins First Xarelto Trial in Philadelphia ($27.8M)

On December 5, 2017, an Indiana couple won their Xarelto lawsuit in Philadelphia. The jury ordered that the drug manufacturers, Bayer AG and Johnson & Johnson (J&J), pay $27.8 million for failing to warn about the blood-thinner’s serious side effects. […]

Derek T. Braslow

Nuedexta: Did Greed Push this Pill’s Popularity?

Avanir Pharmaceuticals manufactures Nuedexta, a prescription drug medication approved by the Food and Drug Administration (FDA) to treat a rare condition—pseudobulbar affect (PBA)—where sufferers experience uncontrollable laughing and crying. Yet, a recent CNN investigation has found that doctors increasingly are […]

Eric Washburn

Dangerous Drugs and the Injuries Victims Suffer

Despite the required testing and approval process put in place by the Food and Drug Administration (FDA), dangerous drugs still end up on the market and drug recalls take place. Even though clinical trials are supposed to find any safety […]

Eric T. Chaffin

Plaintiffs Seek Consolidation of Onglyza Lawsuits

Back in July 2009, the FDA approved the new drug Onglyza (saxagliptin) for the treatment of type 2 diabetes. In 2014, however, they issued a drug safety communication stating that they had requested additional clinical trial data from the manufacturers, […]

Brett Emison

Trial Court: Bair Hugger Warming Blanket Lawsuits Will Proceed to Trial

In a critical victory for victims of Bair Hugger warming blanket infections, the trial judge presiding over thousands of hip and knee joint infection lawsuits ruled this week that the claims will continue against 3M over its Bair Hugger forced […]